Latest news
Loading news…
Chiesi Farmaceutici
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Parma, Emilia-Romagna, Italy Founded 1935 5001-10000 employees For Profit
Chiesi Farmaceutici provides research, development, production, and marketing of medicines for respiratory, neonatology, rare diseases.
Chiesi Farmaceutici on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Last Funding
Acquisitions
5
Investments
3
3 exits
Monthly Visits
Contacts
1,270
Patents
574
259 trademarks
About Chiesi Farmaceutici
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Mobile apps
- 2
- Active products
- 28
- Patents granted
- 574
- Trademarks
- 259
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $71.4M
Investor Activity
- Investments
- 3
- Lead investments
- 1
- Portfolio orgs
- 3
- Exits
- 3
- Exits via IPO
- 2
Company Info
- Founded
- 1935
- Employees
- 5001-10000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- News articles
- 150
- HQ
- Parma, Emilia-Romagna, Italy
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.5
- Trend (30d)
- -3.8
- Trend (90d)
- 3.7
- Last leadership hire
- May 15, 2026
Chiesi Farmaceutici Investments
Loading columns…
0 of 0Show
Page 1 / 1
Chiesi Farmaceutici Acquisitions
5 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals | $1.9B | 2026-04-29 | Chiesi Farmaceutici | Acquisition | Cash & Stock | BiopharmaBiotechnologyDiabetesHealth CarePharmaceutical | Cambridge | United States | KalVista Pharmaceuticals focuses on developing oral medicine… | 2011-01-01 | 251-500 | BiotechnologyHealth CareMedicalPharmaceutical | Italy | 5001-10000 | Private | 5 | www.kalvista.com | |
| Amryt Pharma | $1.25B | 2023-01-08 | Chiesi Farmaceutici | Acquisition | Cash | BiopharmaLife ScienceMedicalPharmaceutical | Dublin | Ireland | Amryt Pharma creates and delivers innovative treatments to h… | 2012-01-01 | 251-500 | BiotechnologyHealth CareMedicalPharmaceutical | Italy | 5001-10000 | Private | 5 | www.amrytpharma.com | |
| Atopix Therapeutics | — | 2016-11-21 | Chiesi Farmaceutici | Acquisition | — | BiotechnologyLife ScienceMedical | Abingdon | United Kingdom | Atopix Therapeutics Limited is a privately held, clinical-st… | 2012-01-01 | 1-10 | BiotechnologyHealth CareMedicalPharmaceutical | Italy | 5001-10000 | Private | 5 | atopixtherapeutics.co.uk | |
| Cornerstone Therapeutics | — | 2014-02-04 | Chiesi Farmaceutici | Acquisition | — | BiotechnologyHealth CareTherapeutics | Cary | United States | Cornerstone Therapeutics is a pharmaceutical company focused… | 2000-01-01 | 51-100 | BiotechnologyHealth CareMedicalPharmaceutical | Italy | 5001-10000 | Private | 5 | www.crtx.com | |
| Zymenex | — | 2013-08-26 | Chiesi Farmaceutici | Acquisition | — | BiotechnologyGeneticsHealth CareTherapeutics | Hillerød | Denmark | Zymenex is a Scandinavian biopharmaceutical company focused … | 1998-01-01 | 11-50 | BiotechnologyHealth CareMedicalPharmaceutical | Italy | 5001-10000 | Private | 5 | www.zymenex.com |
1–5 of 5Show
Page 1 / 1
Chiesi Farmaceutici Key People
Director
Vice Chairman
Head of Real World Evidence, R&D Global Clinical Development
Project Leader
Chairman
Global Rare Diseases, Research & Development Head
Head of Regulatory Affairs "Rest of the World"
Group CFO
Project Leader and Technical Leader
Senior Manager, Regulatory CMC
CCO
1,270
professional contacts at Chiesi Farmaceutici
Contact execs at Chiesi Farmaceutici →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Chiesi Farmaceutici
Loading news…
FAQs about Chiesi Farmaceutici
People who checked this page also checked these
Sectors Chiesi Farmaceutici invests & acquires in
Browse the full Acquirezy directory.